To delineate the role of PSMA4 in lung cancer more distinctly, the integrated results from this meta-analysis further substantiate the notion that PSMA4 is a promising therapeutic target in lung cancer, offering a potential avenue for targeted treatment strategies (Figure 3C). Here, PSMA4 is linked to lung carcinoma.